About Us


Starton Therapeutics is an emerging clinical-stage biotechnology company transforming standard of care therapies with proprietary dermal delivery technology, so people with cancer can receive continuous treatment to live better, longer.

We transform FDA-approved medicines and leverage our delivery system to establish new profiles. Our platform technology allows for lower drug exposure and the potential for improved efficacy.

Starton is led by a world-class team comprised of experienced industry professionals and clinical opinion leaders. We strengthen our capabilities through collaborations with industry-leading firms. We are committed to developing bold solutions to address unmet medical needs, moving together with quality and speed to deliver on our commitment to patients.

Contact Us